Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 24595299)

1.

Endoscope-guided interstitial intensity-modulated brachytherapy and intracavitary brachytherapy as boost radiation for primary early T stage nasopharyngeal carcinoma.

Wan XB, Jiang R, Xie FY, Qi ZY, Li AJ, Ye WJ, Hua YJ, Zhu YL, Zou X, Guo L, Mai HQ, Guo X, Hong MH, Chen MY.

PLoS One. 2014 Mar 3;9(3):e90048. doi: 10.1371/journal.pone.0090048. eCollection 2014.

2.

Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease.

Leung TW, Tung SY, Wong VY, Sze WK, Lui CM, Wong FC, Lee AS, O SK.

Cancer. 2005 Oct 15;104(8):1648-55.

3.

High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}.

Leung TW, Wong VY, Sze WK, Lui CM, Tung SY.

Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):361-7. Epub 2007 Sep 24.

PMID:
17892917
4.

Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.

Leung TW, Tung SY, Sze WK, Sze WM, Wong VY, O SK.

Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):405-12.

PMID:
10802367
5.
7.

Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma.

Leung TW, Tung SY, Sze WK, Sze WM, Wong VY, Wong CS, O SK.

Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1331-8.

PMID:
11121630
8.

[Long-term efficacy of external radiotherapy plus intracavitary hyperfractionated brachytherapy on nasopharyngeal carcinoma].

Lin SJ, Pan JJ, Wu JX, Han L, Pan CZ.

Ai Zheng. 2007 Feb;26(2):208-11. Chinese.

PMID:
17298755
9.
10.

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.

Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, Akazawa P, Weinberg V, Fu KK.

Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):12-22.

PMID:
12007936
11.

Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.

Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1440-50.

PMID:
15590175
12.

Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution's 45-year experience.

Lee N, Hoffman R, Phillips TL, Xia P, Quivey JM, Weinberg V, Hsu IC.

Brachytherapy. 2002;1(2):74-82.

PMID:
15062174
13.

Addition of intracavitary brachytherapy to external beam radiation therapy for T1-T2 nasopharyngeal carcinoma.

Wu J, Guo Q, Lu JJ, Zhang C, Zhang X, Pan J, Tham IW.

Brachytherapy. 2013 Sep-Oct;12(5):479-86. doi: 10.1016/j.brachy.2012.10.004. Epub 2013 Mar 5.

PMID:
23466362
14.

The role of brachytherapy in early-stage nasopharyngeal carcinoma.

Chang JT, See LC, Tang SG, Lee SP, Wang CC, Hong JH.

Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):1019-24.

PMID:
8985022
15.

3D-CT implanted interstitial brachytherapy for T2b nasopharyngeal carcinoma.

Ren YF, Gao YH, Cao XP, Ye WJ, Teh BS.

Radiat Oncol. 2010 Nov 23;5:113. doi: 10.1186/1748-717X-5-113.

16.

Improved local control for early T-stage nasopharyngeal carcinoma--a tale of two hospitals.

Teo PM, Leung SF, Fowler J, Leung TW, Tung Y, O SK, Lee WY, Zee B.

Radiother Oncol. 2000 Nov;57(2):155-66.

PMID:
11054519
17.

Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ, Fu KK.

Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):711-22.

PMID:
11020568
18.

Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution.

Yi JL, Gao L, Huang XD, Li SY, Luo JW, Cai WM, Xiao JP, Xu GZ.

Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):161-8. Epub 2006 Mar 20.

PMID:
16542792
19.

Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma.

Yau TK, Sze WM, Lee WM, Yeung MW, Leung KC, Hung WM, Chan WI.

Head Neck. 2004 Dec;26(12):1024-30.

PMID:
15390194
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk